The Patent Finder
US

Sublingual Apomorphine

US 10,420,763 In force, term unresolved
OverviewFamilyAssignmentsSources & methods

Term ends no later than Jun 11, 2030 · Medium confidence

In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.

Filed Jun 11, 2018 as application 16/005,105 · Granted Sep 24, 2019
Base term, 20 years from filing
Today
20 years from filing
2010 2030
Clock starts
Jun 11, 2010
Ends no later than
Jun 11, 2030
Granted
Sep 24, 2019
base term fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
1 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
10
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. 1 of 2 maintenance fees is paid so far. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jun 11, 2010, when application 12/813,820, the earliest non-provisional in its chain, was filed (this one was filed Jun 11, 2018)Jun 11, 2030High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer on file (approved), reference document not resolvedno cap applied, and none guessedMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 2 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderno later than Jun 11, 2030Medium confidence

This family

US 9,044,475In force
no later than Jun 2030
no later than Jun 2030
US 9,326,981In force
Jun 2030
Jun 2030
Application 14/962,806Abandoned
not computed
not computed
US 9,669,018Lapsed on the fee record
Jun 2025
Jun 2025
US 9,669,020Lapsed on the fee record
Jun 2025
Jun 2025
US 9,669,019Lapsed on the fee record
Jun 2025
Jun 2025
US 9,669,021Lapsed on the fee record
Jun 2025
Jun 2025
US 10,420,763this patent
no later than Jun 2030
no later than Jun 2030
8 of 10 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Apr 16, 2019
Reel 48895, frame 521
Giovinazzo, Anthony John; Hedden, David Bruce; De Somer, MarcAdagio Pharmaceuticals, Ltd.Assignment of Assignor's Interest
Apr 16, 2019
Reel 48895, frame 639
Bryson, Nathan JohnCynapsus Therapeutics, Inc.Assignment of Assignor's Interest
Apr 16, 2019
Reel 48895, frame 798
Adagio Pharmaceuticals Ltd.Cynapsus Therapeutics, Inc.Assignment of Assignor's Interest
Apr 16, 2019
Reel 48896, frame 20
Sunovion CNS Development Canada ULCSunovion Pharmaceuticals Inc.Assignment of Assignor's Interest
Apr 16, 2019
Reel 48918, frame 485
Cynapsus Therapeutics Inc.Project Pegasus Sub Acquisition ULCAssignment of Assignor's Interest
Apr 16, 2019
Reel 49828, frame 582
Project Pegasus Sub Acquisition ULCSunovion CNS Development Canada ULCMerger

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited